Keywords: Russia, Investment, Drug-making capacity, AIPM

Big pharma may invest billion euros in Russia in coming years

Article | 18 February 2011

According to the AIPM, these are only initial investments, which may significantly increase at the next stages of the companies& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in